PROTECT YOUR DNA WITH QUANTUM TECHNOLOGY
Orgo-Life the new way to the future Advertising by AdpathwayA review published in Molecular Cancer evaluates the evolving role of nonsense-mediated mRNA decay in cancer biology, tracking its transition from a canonical RNA surveillance mechanism to an active regulator of immune remodeling and targeted therapy. While the pathway was initially recognized for eliminating abnormal transcripts containing premature termination codons, research now identifies it as a broader posttranscriptional regulator of transcript fate, cellular protein homeostasis, stress adaptation, and tumor immune recognition.
In malignant environments, cancer cells frequently generate aberrant transcripts driven by underlying genomic instability and abnormal RNA processing. Rather than facing uniform destruction, these aberrant transcripts demonstrate distinct levels of susceptibility to decay; certain transcripts experience efficient degradation, whereas others undergo only partial breakdown or manage to escape surveillance entirely.
This marked variation in decay sensitivity provides a molecular explanation for why nonsense-mediated mRNA decay can alternately promote or suppress tumor progression across different cancers. The review emphasizes that the pathway’s precise biological consequences in tumors are fundamentally governed by substrate identity, degradation efficiency, the specific tumor genetic background, and the surrounding immune microenvironment.
The authors analyze key mechanisms underlying pathway biology, focusing on how activation, substrate selection, variable efficiency, and decay escape operate within neoplastic cells. Furthermore, observations demonstrate that pathway efficiency is not static, exhibiting substantial natural variation across different human tissues, individual patients, and distinct tumor contexts.
These surveillance dynamics significantly alter tumor cell adaptation, direct antigen presentation, and dictate how effectively malignant cells are recognized by the immune system. Consequently, the differential regulation of messenger RNA stability directly influences tumor immune responses and shapes resulting therapeutic outcomes.
Finally, the review assesses emerging therapeutic strategies designed to modulate the pathway, including direct pathway inhibition, the targeted modulation of specific substrates, premature termination codon readthrough, and combination therapies. Because the biological and clinical effects depend on substrate identity and tumor context, the authors propose that selective modulation tailored to relevant substrates is preferable to uniform pathway modulation, noting that future research must identify functional substrates and establish tumor-specific dependencies.
Subject of Research: Nonsense-mediated mRNA decay mechanisms, tumor immunity, and cancer therapeutics
Article Title: Nonsense-mediated mRNA decay in cancer: from substrate specificity to immune remodeling and targeted therapy
Article References: Jin, M., Li, Q., Feng, Q., Li, T., Zhang, D., Guo, G., Hao, Y., & Wang, D. (2026). Nonsense-mediated mRNA decay in cancer: from substrate specificity to immune remodeling and targeted therapy. Molecular Cancer. https://doi.org/10.1186/s12943-026-02834-z
Image Credits: AI Generated
DOI: 10.1186/s12943-026-02834-z
Keywords: nonsense-mediated mRNA decay, RNA surveillance, premature termination codons, posttranscriptional regulation, transcript fate, protein homeostasis, cellular stress adaptation, tumor immune recognition, aberrant transcripts, genomic instability, RNA processing, NMD escape, substrate specificity, antigen presentation, PTC readthrough, selective NMD modulation


3 hours ago
19




















English (US) ·
French (CA) ·